Plexus Corp. (NASDAQ:PLXS – Get Free Report) has received a consensus rating of “Hold” from the five research firms that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $159.00.
A number of analysts have issued reports on PLXS shares. Needham & Company LLC raised their target price on Plexus from $158.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Williams Trading set a $165.00 price target on Plexus in a research note on Monday, September 22nd. Benchmark restated a “buy” rating and issued a $165.00 price objective on shares of Plexus in a research note on Friday, October 24th. Sidoti downgraded shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective on the stock. in a report on Friday, October 24th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th.
Read Our Latest Stock Report on PLXS
Plexus Stock Performance
Plexus (NASDAQ:PLXS – Get Free Report) last released its earnings results on Wednesday, October 22nd. The technology company reported $2.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.30. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the prior year, the firm earned $1.85 EPS. The company’s revenue was up .7% compared to the same quarter last year. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. On average, research analysts predict that Plexus will post 5.9 EPS for the current year.
Insider Buying and Selling at Plexus
In other Plexus news, COO Oliver K. Mihm sold 2,327 shares of the business’s stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $143.18, for a total transaction of $333,179.86. Following the sale, the chief operating officer owned 18,442 shares of the company’s stock, valued at $2,640,525.56. The trade was a 11.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Patrick John Jermain sold 2,000 shares of the firm’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $143.53, for a total value of $287,060.00. Following the completion of the transaction, the chief financial officer directly owned 16,961 shares of the company’s stock, valued at $2,434,412.33. The trade was a 10.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 14,172 shares of company stock valued at $2,013,815 over the last 90 days. 1.76% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Plexus
Several hedge funds and other institutional investors have recently modified their holdings of PLXS. Salomon & Ludwin LLC bought a new position in shares of Plexus in the third quarter valued at approximately $30,000. Huntington National Bank lifted its stake in Plexus by 41.5% in the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after purchasing an additional 95 shares in the last quarter. Banque Transatlantique SA purchased a new stake in Plexus in the 1st quarter worth approximately $71,000. Johnson Financial Group Inc. bought a new position in Plexus in the 3rd quarter valued at $72,000. Finally, CWM LLC grew its position in shares of Plexus by 65.7% during the 2nd quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after purchasing an additional 213 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors.
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
- Five stocks we like better than Plexus
- What Is WallStreetBets and What Stocks Are They Targeting?
- Meta Platforms May Ditch NVIDIA Chips—Here’s Why Investors Care
- Do ETFs Pay Dividends? What You Need to Know
- SoFi Technologies: From Fintech Speculation to Profit Engine
- The 3 Best Blue-Chip Stocks to Buy Now
- Gold to $5,000? What Bank of America and UBS Have to Say
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
